Rosett Max's Form 4 filing
Immunome Inc. (IMNM) · filed Sep 20, 2024
- Accession no.
- 0001415889-24-023809
- Filed
- Sep 20, 2024
- Trade date
- Sep 19, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $230.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rosett MaxCIK 0001994071 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2024 | Common Stock | MOption exerciseAcquired | +42,000 | $1.05 | +$44,100 | 61,856 | Direct | |
| Sep 19, 2024 | Common Stock | SSaleDisposed | −14,380 | $16.01 | −$230,223.8 | 47,476 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2024 | Common Stock | MOption exerciseDisposed | −42,000 | $0.00 | $0 | 91,848 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.